2025 American Thyroid Association Management Guidelines for Adult Patients With Differentiated Thyroid Cancer: What's New for Surgeons?
- 1Ventura County Medical Center Ventura California USA
- 2Endeavor Health–teaching affiliate of the University of Chicago Evanston Illinois USA
- 3Cleveland Clinic Cleveland Ohio USA
Abstract
The American Thyroid Association (ATA) has published an update to the 2015 management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer (DTC). This updated version focuses solely on the management of differentiated thyroid cancer, offering a comprehensive set of guidelines for all stakeholders in the care of differentiated thyroid cancer, but no longer addresses the management of thyroid nodules in adults. Herein, we highlight the key updates and differences between the two versions, emphasizing those most pertinent to endocrine neck surgeons. These guidelines will form the basis for differentiated thyroid cancer care over the next few years, affecting millions of patients. For maximal impact, they will need to be widely disseminated, discussed, and dissected, to ultimately result in practice changes befitting the latest evidence‐based care.
Related
- Comparison and calibration of the 2025 and 2015 American Thyroid Association recurrence-risk classifications in differentiated thyroid cancer
- American Academy of Pain Medicine consensus guidelines on neuromodulation technologies and neurocomputer interfaces for pain management and functional recovery
- The Management of Type 1 Diabetes in Adults. The Updated 2026 Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA): Developed by the task force on the management of cardiovascular disease and chronic kidney disease of the European Society of Cardiology (ESC)
- The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
BibTeX
@article{nguyen20262025,
title = {{2025 American Thyroid Association Management Guidelines for Adult Patients With Differentiated Thyroid Cancer: What's New for Surgeons?}},
author = {Chau Nguyen and Amanda Silver Karcioglu and Joseph Scharpf},
journal = {Otolaryngology--Head and Neck Surgery},
year = {2026},
month = aug,
doi = {10.1002/ohn.70367},
url = {https://doi.org/10.1002/ohn.70367},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - 2025 American Thyroid Association Management Guidelines for Adult Patients With Differentiated Thyroid Cancer: What's New for Surgeons?
AU - Chau Nguyen
AU - Amanda Silver Karcioglu
AU - Joseph Scharpf
PY - 2026
DA - 2026/08/06
JO - Otolaryngology--Head and Neck Surgery
DO - 10.1002/ohn.70367
UR - https://doi.org/10.1002/ohn.70367
AB - The American Thyroid Association (ATA) has published an update to the 2015 management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer (DTC). This updated version focuses solely on the management of differentiated thyroid cancer, offering a comprehensive set of guidelines for all stakeholders in the care of differentiated thyroid cancer, but no longer addresses the management of thyroid nodules in adults. Herein, we highlight the key updates and differences between the two versions, emphasizing those most pertinent to endocrine neck surgeons. These guidelines will form the basis for differentiated thyroid cancer care over the next few years, affecting millions of patients. For maximal impact, they will need to be widely disseminated, discussed, and dissected, to ultimately result in practice changes befitting the latest evidence‐based care.
SN - 0194-5998
SN - 1097-6817
ER -